Diabetes Products Should Be Exempt From Competitive Bidding – Panel
This article was originally published in The Gray Sheet
Executive Summary
Supplier and manufacturer stakeholders are urging CMS to exclude blood glucose testing products from the impending DMEPOS competitive bidding program
You may also be interested in...
BD Exits Glucose Monitoring Market After Being “Eclipsed” By Competitors
Becton Dickinson is dropping out of the increasingly competitive blood glucose monitoring market, acknowledging that it has been too slow to innovate in a sector that generated about $105 mil. in BD sales for the 12 months ended Sept. 30
BD Exits Glucose Monitoring Market After Being “Eclipsed” By Competitors
Becton Dickinson is dropping out of the increasingly competitive blood glucose monitoring market, acknowledging that it has been too slow to innovate in a sector that generated about $105 mil. in BD sales for the 12 months ended Sept. 30
DMEPOS codes reviewed
CMS has made preliminary decisions regarding 112 requests for changes to HCPCS codes for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) in 2007. The agency will hear public comments on the decisions in a series of meetings from April 25 to May 5. During a Program Advisory & Oversight Committee meeting in September, DMEPOS stakeholders stressed the need to update and expand HCPCS codes for their products before competitive bidding is instituted in 2007. Without the update, suppliers under the system may hamper beneficiary access by providing the lowest quality products within each code, they warned (1"The Gray Sheet" Oct. 3, 2005, p. 15)...